Free Trial

Life Science REIT (LON:LABS) Stock Price Up 1.1% - Here's Why

Life Science REIT logo with Real Estate background

Key Points

  • Life Science REIT plc shares rose 1.1% during mid-day trading, reaching GBX 37.90 ($0.50), although the trading volume decreased by 40% compared to its average.
  • The company reported a negative earnings per share (EPS) of GBX (8.50), along with a negative return on equity of 14.53% and a negative net margin of 198.99% for the last quarter.
  • Life Science REIT, a closed-ended Real Estate Investment Trust incorporated in England and Wales, began trading on the London Stock Exchange on November 19, 2021.
  • Five stocks to consider instead of Life Science REIT.

Life Science REIT plc (LON:LABS - Get Free Report) shares rose 1.1% during mid-day trading on Tuesday . The stock traded as high as GBX 38.20 ($0.51) and last traded at GBX 37.90 ($0.50). Approximately 479,795 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 800,494 shares. The stock had previously closed at GBX 37.50 ($0.50).

Life Science REIT Trading Up 0.8%

The firm's 50-day moving average price is GBX 38.31 and its 200 day moving average price is GBX 41.37. The company has a market cap of £133.70 million, a price-to-earnings ratio of -434.09 and a beta of 0.08.

Life Science REIT (LON:LABS - Get Free Report) last issued its earnings results on Tuesday, September 23rd. The company reported GBX (8.50) earnings per share (EPS) for the quarter. Life Science REIT had a negative return on equity of 14.53% and a negative net margin of 198.99%.

About Life Science REIT

(Get Free Report)

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Life Science REIT Right Now?

Before you consider Life Science REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.

While Life Science REIT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.